CDC's 8.5% XDR Shigella warning puts UAE ER stool testing under pressure

Treatment-resistant Shigella, a bacterial cause of severe diarrhoea that can spread through sexual contact, is now a practical triage issue for UAE emergency departments, urgent care clinics and insurers after US surveillance found extensively drug-resistant isolates rose to 8.5% in 2023.

The story reported by Gulf Coast News and Weather follows a 9 April 2026 CDC MMWR report and a 9 July 2026 University of Cambridge study. The highest-stakes readers in the UAE are COOs, medical directors and payer medical teams. They need to know when diarrhoea becomes a stool-culture, antimicrobial-susceptibility and notification workflow, rather than a routine gastroenteritis visit.

What the outbreak signal says

The CDC analysed 16,788 Shigella isolates collected from 1 January 2011 to 20 October 2023. It found 510 extensively drug-resistant isolates. The proportion increased from 0% during 2011-2015 to 8.5% in 2023. Among patients with available age and sex data, 86.2% were men and the median age was 41 years.

Most infections resolve without requiring treatment with antimicrobial agents; however, antibiotics are indicated for severe illness or to reduce transmission in high-risk settings. — Centers for Disease Control and Prevention, MMWR, 9 April 2026

The UK signal is similar. Cambridge researchers said sexually transmitted Shigella variants are spreading quickly in parts of the LGBTQ+ community and developing resistance to key antibiotics. The university cited 2,560 UKHSA-recorded cases in 2025 that were potentially acquired during sexual contact.

For UAE clinicians, the relevant clinical point is narrow. Shigella spreads through fecal-oral exposure, including oral-anal sexual contact. It can cause bloody or prolonged diarrhoea, fever, abdominal pain and dehydration. CDC clinical guidance says many cases improve in 5 to 7 days, but clinicians can order stool testing to identify resistant infection and should avoid gut-slowing medicines such as loperamide in suspected shigellosis.

Dubai clinics need a reporting and testing script

Dubai providers should treat suspected resistant Shigella as a protocol issue under Dubai Health Authority (DHA) communicable disease rules. DHA's notifiable disease list places Shigellosis under food-borne illness for electronic reporting within 24 hours in its published school clinic standards, and a 27 December 2023 DHA circular directed all Dubai health professionals and facilities to the Communicable Disease Notification Policy.

The operational gap is history-taking. A patient presenting with diarrhoea may not volunteer recent sexual exposure, recent travel, HIV status, antibiotic use or contact with a symptomatic partner. Emergency and urgent care operators should add two private screening questions to diarrhoea intake forms and make stool culture or multiplex stool PCR plus susceptibility follow-up available when symptoms are severe, bloody, prolonged, recurrent or linked to a cluster.

• COO: confirm who files DHA notification and who follows stool susceptibility results after discharge.
• Medical director: review empiric antibiotic rules for bloody diarrhoea and immunocompromised patients.
• CFO: check whether stool PCR, culture and sensitivity are billed under the patient's network or need insurer approval.
• CIO: add Shigellosis prompts and reporting fields into ED and urgent care templates.

Cash prices for stool culture, multiplex gastrointestinal PCR and sensitivity testing vary by UAE facility and laboratory contract. Operators should verify current tariffs in their own billing master, insurer portals and laboratory service agreements rather than rely on public price lists. For insured patients, network eligibility and co-pay should be checked before non-emergency outpatient testing.

Abu Dhabi and northern emirates should watch payer routing

In Abu Dhabi, the relevant regulator is the Department of Health Abu Dhabi (DOH). DOH's public health reporting standard lists Shigellosis as reportable by electronic notification within one calendar day. Older DOH communicable disease data reported 22 shigellosis cases in 2018 and 23 in 2017 across Abu Dhabi emirate, with cases submitted through electronic notification.

For the northern emirates, the relevant regulator is the Ministry of Health and Prevention (MOHAP). MOHAP published Ministerial Decree No. 242 of 2020 updating the UAE list of notifiable communicable diseases. Providers in Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain should use MOHAP channels and their emirate-specific facility licence obligations when suspected cases meet notification criteria.

Insurers have a narrower task. Daman and Thiqa route Abu Dhabi patients through listed provider networks, while Sukoon publishes a UAE network search and says its health members can select from more than 3,500 network facilities. Payers should make sure emergency departments and urgent care clinics know when stool testing is covered at point of care, when pre-authorisation applies and how claims are coded if Shigella is reported as both enteric infection and sexually associated transmission.

Patients with severe dehydration, bloody diarrhoea, high fever, pregnancy, immunocompromise or symptoms lasting more than 3 days should seek medical care and tell the clinician about recent travel, antibiotics and sexual exposure. UAE operators should direct patients to licensed emergency care rather than informal advice channels. For licensed options, use the UAE Open Healthcare Directory and filter for emergency care providers in Dubai, Abu Dhabi and the northern emirates.